Rankings
▼
Calendar
PMVP Q3 2022 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$84M
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$19M
Net Income
-$18M
EPS (Diluted)
$-0.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$19M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$285M
Total Liabilities
$24M
Stockholders' Equity
$261M
Cash & Equivalents
$100M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$19M
-$15M
-28.3%
Net Income
-$18M
-$15M
-21.4%
← FY 2022
All Quarters
Q4 2022 →